Commentary [ Research Highlights(To miR or Not to miR: That is the Question in ALS Disease ]

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 648-649

Bentham Science Publishers

Access to resources Recommend Favorite

The role of miR-145 in microvasculature

By Ji Li-ya   Jiang De-qian   Dong Ni-ni  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 6, 2013-06 ,pp. : 387-391

Govi-Verlag

Access to resources Recommend Favorite

Serum miR‐146a, miR‐155, and miR‐210 as potential markers of Graves’ disease

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma

By  

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 503-508

Bentham Science Publishers

Access to resources Recommend Favorite

miR-210: a therapeutic target in cancer

By Hong Liu   Han Yu   Zhang Hongwei   Zhao Qingchuan   Qiao Yuan  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 21-28

Informa Healthcare

Access to resources Recommend Favorite